Search Results - Cebon, J.

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide by Cebon, J

Get full text Get full text Get full text

Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer. by Cebon, J. S., Bishop, J. F., Harvey, V., Mason, B., Jeal, P. N.

Get full text Get full text

Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes. by Hamilton, J A, Whitty, G A, Royston, A K, Cebon, J, Layton, J E

Get full text Get full text

Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia. by Waring, P M, Presneill, J, Maher, D W, Layton, J E, Cebon, J, Waring, L J, Metcalf, D

Get full text Get full text

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. by Stanley, E, Lieschke, G J, Grail, D, Metcalf, D, Hodgson, G, Gall, J A, Maher, D W, Cebon, J, Sinickas, V, Dunn, A R

Get full text Get full text

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications by Sigalotti, L, Coral, S, Altomonte, M, Natali, L, Gaudino, G, Cacciotti, P, Libener, R, Colizzi, F, Vianale, G, Martini, F, Tognon, M, Jungbluth, A, Cebon, J, Maraskovsky, E, Mutti, L, Maio, M

Get full text Get full text Get full text

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy by Bowyer, S, Prithviraj, P, Lorigan, P, Larkin, J, McArthur, G, Atkinson, V, Millward, M, Khou, M, Diem, S, Ramanujam, S, Kong, B, Liniker, E, Guminski, A, Parente, P, Andrews, M C, Parakh, S, Cebon, J, Long, G V, Carlino, M S, Klein, O

Get full text Get full text Get full text

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma by Halse, H., Colebatch, A. J., Petrone, P., Henderson, M. A., Mills, J. K., Snow, H., Westwood, J. A., Sandhu, S., Raleigh, J. M., Behren, A., Cebon, J., Darcy, P. K., Kershaw, M. H., McArthur, G. A., Gyorki, D. E., Neeson, P. J.

Get full text Get full text Get full text

Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide by Cebon, J, Findlay, M, Hargreaves, C, Stockler, M, Thompson, P, Boyer, M, Roberts, S, Poon, A, Scott, A M, Kalff, V, Garas, G, Dowling, A, Crawford, D, Ring, J, Basser, R, Strickland, A, Macdonald, G, Green, M, Nowak, A, Dickman, B, Dhillon, H, Gebski, V

Get full text Get full text

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma by Wolchok, J.D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C.L., Lao, C.D., Wagstaff, J., Schadendorf, D., Ferrucci, P.F., Smylie, M., Dummer, R., Hill, A., Hogg, D., Haanen, J., Carlino, M.S., Bechter, O., Maio, M., Marquez-Rodas, I., Guidoboni, M., McArthur, G., Lebbé, C., Ascierto, P.A., Long, G.V., Cebon, J., Sosman, J., Postow, M.A., Callahan, M.K., Walker, D., Rollin, L., Bhore, R., Hodi, F.S., Larkin, J.

Get full text Get full text Get full text